BRIEF published on 08/09/2024 at 17:09, 1 year 7 months ago Subsidiaries of Vita 34 Reach Agreement with US Licensor Vita 34 FamiCordTx PBKM CAR-T Technology Biotechnology Agreement
PRESS RELEASE published on 08/09/2024 at 17:04, 1 year 7 months ago EQS-Adhoc: Subsidiaries of Vita 34 reach agreement with US licensor Vita 34 AG subsidiaries reach agreement with US licensor on CAR-T technology, settling previous lawsuit and securing new know-how licensing agreement Vita 34 AG Agreement Subsidiaries CAR-T Technology US Licensor
BRIEF published on 08/01/2024 at 12:44, 1 year 7 months ago Thomas Pfaadt Appointed as New Chief Financial Officer of Vita 34 AG Chief Financial Officer Finance Management Board Vita 34 AG Thomas Pfaadt
PRESS RELEASE published on 08/01/2024 at 12:39, 1 year 7 months ago Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG Thomas Pfaadt appointed as new CFO of Vita 34 AG, bringing 20+ years of experience. Management Board complete. Vita 34, leading cell bank in Europe, focusing on cell banking and investments in therapies CFO Vita 34 AG Investments Thomas Pfaadt Cell Banking
BRIEF published on 05/31/2024 at 08:38, 1 year 9 months ago Vita 34 Reports Significant Increases in Earnings and Cash Flow EBITDA Revenue Growth Operating Cash Flow Q1 2024 Earnings Vita 34
PRESS RELEASE published on 05/31/2024 at 08:33, 1 year 9 months ago Vita 34 significantly increases earnings and operating cash flow in the first quarter Vita 34 AG reports a significant increase in earnings and operating cash flow in the first quarter of 2024, with revenues up by 3.6% to EUR 18.6 million. EBITDA exceeds EUR 1.5 million Revenues Business Development Earnings Operating Cash Flow Vita 34 AG
BRIEF published on 04/30/2024 at 22:56, 1 year 10 months ago Vita 34 Sees Financial Growth and Improvement in 2023 Investment Strategies 2024 Outlook Vita 34 AG Financial Growth Increase In EBITDA
PRESS RELEASE published on 04/30/2024 at 22:51, 1 year 10 months ago Vita 34 returns to growth path in 2023 Vita 34 AG reports 11.8% revenue growth to EUR 77.1 million in 2023 despite challenging environment. EBITDA significantly improved to EUR 5.6 million EBITDA Revenue Growth Business Development Vita 34 AG Cell Bank
BRIEF published on 04/19/2024 at 12:33, 1 year 11 months ago Vita 34 Achieves Better Than Expected Financial Results for 2023 EBITDA Revenue Growth Financial Performance Earnings Report Vita 34 AG
PRESS RELEASE published on 04/19/2024 at 12:28, 1 year 11 months ago EQS-Adhoc: Vita 34 closes 2023 with significantly better results than expected based on preliminary figures Vita 34 AG exceeds 2023 earnings expectations with EUR 5.6 million EBITDA, forecasts revenues of EUR 81-88 million and EBITDA of EUR 6.5-8.0 million for 2024 Revenues EBITDA Forecast Earnings Vita 34 AG
Published on 03/26/2026 at 22:05, 48 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 53 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 53 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 1 hour 53 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 21:00, 1 hour 53 minutes ago Rocky Shore Closes Acquisition of Additional Mining Claims
Published on 03/26/2026 at 20:48, 2 hours 5 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 3 hours 33 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 3 hours 44 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 4 hours 36 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 07:30, 15 hours 23 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
